Model and method for angiogenesis inhibition
US6117862A · kind A · utility
16Cited by
12References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 1998 |
| Grant date | Sep 12, 2000 |
| Priority date | — |
| Expiry date | Oct 9, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method to inhibit the formation of neovasculature while maintaining viability of the underlying tissue by subjecting a subject in which angiogenesis is to be inhibited to sublethal photodynamic therapy. The invention also provides a model for assessing sublethal PDT protocols to inhibit angiogenesis in particular target tissues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.